Jury In Sophos Trial Awards FNJN $15 million

By Lisa Thompson Finjan (NASDAQ:FNJN) won its trial against Sophos yesterday and was awarded $ 15 million for the life of the patents. This was at the high end of the range that an expert witness sug...

CERC: Multiple Catalysts Upcoming in 4Q16

By David Bautz, PhD NASDAQ:CERCBusiness UpdateCerecor, Inc. (NASDAQ:CERC) is a clinical stage biopharmaceutical company developing treatments for patients with neurological and psychiatric disorders....